Synopsis: Neuralink has begun its first human trials with 29-year-old Noland Arbaugh, who was paralyzed from the shoulders down. Elon Musk, Neuralink’s CEO, predicts that brain chips will replace phones, as he mentioned in a post on X. Arbaugh's progress has been promising, with improvements in activities like playing chess. Neuralink is now seeking applications for a second participant in their brain implant trial.
Neuralink has commenced its first human trials with 29-year-old Noland Arbaugh.
Elon Musk envisions that Neuralink's brain chips will eventually replace phones.
Responding to a post on X, Musk stated, "In the future, there will be no phones, just Neuralinks." As CEO of Neuralink, Musk is spearheading the development of brain chip technology.
The human trials involving Arbaugh, who was paralyzed from the shoulders down due to an accident eight years ago, began with brain surgery on January 28. Neuralink recently celebrated the 100-day mark of his recovery, sharing detailed progress in a blog post and a video in March.
Arbaugh has expressed his excitement about the improvements in his ability to engage in activities like playing chess, saying, "It's crazy, so cool. I am lucky to be a part of this. It seems every day I am learning something new. I can't describe how cool it is to be able to do this."
Musk also announced that Neuralink is accepting applications for a second participant in their Telepathy cybernetic brain implant trial, which allows users to control their phones and computers through thought.
Despite the advancements, Neuralink faces challenges, including a lawsuit from former animal care specialist Lindsay Short.
She claims the company failed to provide adequate protective equipment while she cared for animals infected with a dangerous virus that can cause severe brain damage or death in humans.
In conclusion, despite significant advancements and the promising progress of their first human trial, Neuralink faces challenges, including legal issues concerning animal care practices.
As the company continues to innovate with its brain chip technology and seeks new participants for its trials, the future of human-technology integration remains both exciting and contentious.
